IndieBio — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
iOrganBio builds CellForge, an AI- and automation-driven platform for engineering and manufacturing human cells and organoids.
Co-investorsCape Fear BioCapitalFirst Star VenturesHartmann CapitalAlix VenturesSOSV
Puna Bio develops microbial biostimulants, biofertilizers, and biofungicides for seed treatment based on extremophile bacteria collected from Argentina's Puna region, aimed at improving crop yields and regenerating degraded soils.
AgTechBiotechClimate TechSan Francisco, US
Maria Eugenia Farias(Executive Officer)inCarolina Belfiore(Executive Officer)inElisa Violeta Bertini(Executive Officer, Director)inFranco Martinez Levis(Executive Officer, Director)in
BoardDario Maffei(Director)Laurie Menoud(Director)in
Co-investorsAIR CapitalAt One VenturesGLOCAL LatamGRIDXSOSVBuilders VC+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.